Around $1.5M Bet On Abrdn Life Sciences Investors? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform.

Lake Shore Bancorp

• The Trade: Lake Shore Bancorp, Inc. (NASDAQ:LSBK) Director Kevin M. Sanvidge acquired a total of 3,000 shares an average price of $10.81. To acquire these shares, it cost around $32,442..
• What's Happening: On April 22, Lake Shore Bancorp posted a decline in quarterly EPS.
• What Lake Shore Bancorp Does: Lake Shore Bancorp Inc operates as a savings and loan holdings company.

Auburn National Bancorporation

• The Trade: Auburn National Bancorporation, Inc. (NASDAQ:AUBN) President/CEO David A Hedges acquired a total of 10,000 shares at an average price of $17.60. To acquire these shares, it cost around $176,000.
• What's Happening: On April 24, Auburn National Bancorporation posted a decline in quarterly sales.
• What Auburn National Bancorporation Does: Auburn National Bancorp Inc operates as a bank holding company, which offers checking, savings, transaction deposit accounts and certificates of deposit, and is an active residential mortgage lender in its primary service area.

Don’t forget to check out our premarket coverage here

Abrdn Life Sciences Investors

• The Trade: Abrdn Life Sciences Investors (NYSE:HQL) 10% owner Boaz Weinstein bought a total of 120,304 shares at an average price of $13.00. To acquire these shares, it cost around $1.56 million.
• What's Happening: The company's stock gained around 13% over the past six months.
• What Abrdn Life Sciences Investors Does: abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company.

Now Read this: McDonald’s Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts